Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Integrated BioPharma Inc. (INBP) had Cost of Goods Sold of $48.79M for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
$54.35M |
|
$0.81M |
|
|
Cost of Goods Sold |
$48.79M |
$5.56M |
|
$52.33M |
|
$2.02M |
|
$0.04M |
|
$2.06M |
|
$2.06M |
|
$0.81M |
|
$0.81M |
|
$0.81M |
|
$0.81M |
|
$2.02M |
|
$3.29M |
|
30.30M |
|
31.17M |
|
$0.03 |
|
$0.03 |
|
| Balance Sheet Financials | |
$18.76M |
|
$1.72M |
|
$6.14M |
|
$24.90M |
|
$4.25M |
|
$0.12M |
|
$0.34M |
|
$4.58M |
|
$20.32M |
|
$20.32M |
|
$20.32M |
|
31.06M |
|
| Cash Flow Statement Financials | |
$2.06M |
|
$-0.20M |
|
$0.08M |
|
$1.68M |
|
$3.62M |
|
$1.94M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.42 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
10.23% |
|
3.72% |
|
3.72% |
|
6.05% |
|
3.79% |
|
1.49% |
|
$1.87M |
|
-- |
|
-- |
|
-- |
|
2.18 |
|
5.21 |
|
10.01 |
|
36.46 |
|
3.98% |
|
3.98% |
|
3.24% |
|
3.95% |
|
$0.65 |
|
$0.06 |
|
$0.07 |
|